Sami F. Qadri

Helsinki, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Reply to: "Ketogenic diets in MASLD: methodological limitations and the confounding role of protein intake".

Reply to: "Ketogenic diets in MASLD: methodological limitations and the confounding role of protein intake".

Journal: Journal of hepatology

Published: May 05, 2026

Screening and diagnosis of liver disease in diabetes: a guide and evidence-based assessment.

Screening and diagnosis of liver disease in diabetes: a guide and evidence-based assessment.

Journal: Diabetologia

Published: February 20, 2026

Distinct effects of ketogenic and non-ketogenic weight-loss diets on hepatic steatosis and mitochondrial metabolism in MASLD.

Distinct effects of ketogenic and non-ketogenic weight-loss diets on hepatic steatosis and mitochondrial metabolism in MASLD.

Journal: Journal of hepatology

Published: July 22, 2025

Genome-wide interaction study with body mass index identifies CYP7A1 and GIPR as genetic modulators of metabolic dysfunction-associated steatotic liver disease.

Genome-wide interaction study with body mass index identifies CYP7A1 and GIPR as genetic modulators of metabolic dysfunction-associated steatotic liver disease.

Journal: Clinical and molecular hepatology

Published: February 26, 2025

Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease.

Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease.

Journal: Nature medicine

Published: January 29, 2024

A metabolome-derived score predicts metabolic dysfunction-associated steatohepatitis and mortality from liver disease.

A metabolome-derived score predicts metabolic dysfunction-associated steatohepatitis and mortality from liver disease.

Journal: Journal of hepatology

Published: January 09, 2024

Corrigendum to "SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease" [J Hepatol 80 (2024) 10-19].

Corrigendum to "SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease" [J Hepatol 80 (2024) 10-19].

Journal: Journal of hepatology

Published: January 05, 2024

Surveillance of the liver in type 2 diabetes: important but unfeasible?

Surveillance of the liver in type 2 diabetes: important but unfeasible?

Journal: Diabetologia

Published: September 15, 2023

The first human normative ranges and biomarker performance of dimethylguanidino valeric acid isoforms in fatty liver disease.

The first human normative ranges and biomarker performance of dimethylguanidino valeric acid isoforms in fatty liver disease.

Journal: Pathology

Published: June 12, 2023

Marked difference in liver fat measured by histology vs. magnetic resonance-proton density fat fraction: A meta-analysis.

Marked difference in liver fat measured by histology vs. magnetic resonance-proton density fat fraction: A meta-analysis.

Journal: JHEP reports : innovation in hepatology

Published: April 19, 2023

The quest for the missing links in fatty liver genetics: Deep learning to the rescue!

The quest for the missing links in fatty liver genetics: Deep learning to the rescue!

Journal: Cell reports. Medicine

Published: December 21, 2022

Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease.

Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: November 02, 2022

Showing 1-12 of 28

Last Updated: 09/26/2026